GSA Capital Partners’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $827K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $123K | Buy |
|
|||||
|
2024
Q3 | $273K | Sell |
|
|||||
|
2024
Q2 | $303K | Buy |
|
|||||
|
2024
Q1 | $151K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.26M | Buy |
|
|||||
|
2023
Q2 | $772K | Buy |
|
|||||
|
2023
Q1 | $144K | Buy |
|
|||||
|
2022
Q4 | $208K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $727K | Buy |
|